Friday 06 December, Nottingham, England UK. At a black-tie event held in Nottingham last night, 200 leading names and rising stars of the life sciences came together at the Medilink East Midlands Business Awards 2019. A celebration of innovation within the region, a total of seven...
BioCity, the pioneering life science incubator and business collective is set to open its doors to one hundred young women from local schools on Tuesday 08 October 2019. BioCity will be joined by Rolls Royce, The British Army, Twycross Zoo, Boots UK, Sygnature Discovery, XenoGesis and...
MediCity, Nottingham based regenerative medicine company has secured a £1.4m investment to fund clinical trials on its new cutting-edge treatment for dry eye disease. The funding for NuVision Biotherapies Ltd comes in part from the MEIF Proof of Concept & Early Stage Fund, which is managed...
BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers. Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...
MediCity, Nottingham is delighted to announce that the Grade C - GMP Laboratory space is now available to rent. The area started it's refurbishment works earlier this year and the team are delighted with the results. Sara Lloyd, Centre Manager at MediCity explained, "The area covers just...
Award-winning MiAlgae considers move into products for human consumption Algae produced from the “co-products” of Scotland’s whisky industry could be used in health products for human consumption, the MediCity, Glasgow based MiAlgae has predicted. Douglas Martin - whose company MiAlgae was crowned Shell LiveWIRE Young Entrepreneur of the year...
MediCity Nottingham based Locate Therapeutics Ltd is the first firm to receive equity finance investment from the Midlands Engine Investment Fund (MEIF) MEIF is providing £400k as part of a £2million investment that will help the firm to deliver an innovative targeted drugs and...